Attempts to establish “actively acquired tolerance” to homologous and heterologous tumors have been described. Some measure of success was obtained with homologous transplants; no effect was demonstrated with heterologous grafts.

Some of the reasons for failure are discussed, and possible methods of improving the results are considered.


Supported by a grant-in-aid from the National Cancer Institute of Canada.

This content is only available via PDF.